Investment21 Jul 2025, 06:41 pm
Remedium Lifecare Limites Charts Long-Term Growth with Global Subsidiary, Export Contract, and Strong Investor Support
AI Summary
Remedium Lifecare Limited, a fast-growing player in the Pharma Trade and CDMO space, is strengthening its global positioning through strategic initiatives. These include the incorporation of a global subsidiary in Singapore, securing a multi-year export contract, and robust investor participation in a recent rights issue. The company is investing in R&D upgrades, CDMO infrastructure, and expanding into regulated and semi-regulated international markets. Remedium has also partnered with Jia Yu Lifesciences PTE Ltd to strengthen its innovation-led sustainability efforts.
Key Highlights
- Incorporation of a global subsidiary in Singapore for international operations and capital markets interface.
- Secured a 182.7 crore (USD 21 Million) multi-year export contract with a leading pharmaceutical distributor.
- Strong investor participation in the recent rights issue, indicating confidence in the business fundamentals and future potential.
- Investments in R&D upgrades, CDMO infrastructure, and expansion into regulated and semi-regulated international markets.
- Partnership with Jia Yu Lifesciences PTE Ltd to strengthen innovation-led sustainability efforts.